Curcumin-Loaded W/O/W Constructs

• The paper demonstrates the use of ultrasound-assisted, two-stage emulsification with ionic–nonionic surfactant pairing to create stable, submicron curcumin particulates.
• Methodology involves precise control of interfacial tension and droplet geometry to mitigate Ostwald ripening and achieve tunable release kinetics.
• Implications include enhanced particle engineering for poorly soluble APIs, providing scalable opportunities for advanced, sustained drug delivery systems.

Curcumin-loaded water-in-oil-in-water (W/O/W) constructs are engineered multi-compartmental dispersions designed to facilitate the confined precipitation and controlled release of nanometer- to micron-scale curcumin particulates. These systems exploit the physicochemical compartmentalization inherent in W/O/W emulsions to overcome kinetic fragility and solubility limitations, providing tunable templates for particle engineering and drug delivery. Recent work demonstrates robust, ultrasound-assisted preparation of W/O/W constructs with ionic–nonionic surfactant pairings, achieving submicron curcumin-rich particulates and providing a mechanistic foundation for tailored release kinetics (Dhumal, 10 Jan 2026, Pontrelli et al., 2020).

1. Physical Chemistry of W/O/W Emulsions

W/O/W multiple emulsions possess two distinct oil–water interfaces requiring stabilization to prevent droplet coalescence and Ostwald ripening. The Laplace pressure across a droplet of radius $R$ and interfacial tension $\gamma$ is given by:

$\Delta P = \frac{2 \gamma}{R}$

High $\Delta P$ in small droplets increases the energy barrier for coalescence and promotes Ostwald ripening, necessitating effective surfactant adsorption. The adsorption isotherm governing interfacial tension reduction (via the Gibbs equation) is:

$$\Gamma = -\frac{1}{RT}\,\frac{\partial \gamma_{ow}}{\partial \ln c_s}$$

where $c_s$ is the surfactant concentration. Balanced lowering of $\gamma$ at both inner (water/oil) and outer (oil/water) interfaces is essential for kinetic stability. Surfactant pairing, particularly ionic–nonionic combinations (e.g., CTAB in oil and Tween 80 in water), produces robust interfacial films supporting droplet sizes in the $1$–$5\,\mu$m regime with reduced coarsening (Dhumal, 10 Jan 2026).

2. Ultrasound-Assisted, Two-Stage Emulsification

The preparation of curcumin-loaded W/O/W constructs utilizes a two-stage protocol:

• Stage 1 (Primary W/O): High-intensity probe sonication of the oil phase (e.g., cyclohexane, CCl$_4$, or toluene) with dropwise addition of aqueous phase, at $80$–$100\%$ amplitude for $10$ min using a large-diameter ($\sim 12$ mm) probe, maintaining $30^\circ$C. Empirical scaling reveals:

$$d \sim E^{-\alpha},\quad \alpha \approx 0.2\text{--}0.5$$

where $d$ is mean droplet diameter and $E$ is energy density.

• Stage 2 (W/O/W): Gentle addition of the W/O emulsion into an external aqueous phase containing hydrophilic surfactant (Tween 80), under low-shear stirring ($\lesssim 200$ rpm). This preserves primary droplet integrity and suppresses leakage (Dhumal, 10 Jan 2026).

3. Surfactant Selection and Interface Engineering

Ionic–nonionic surfactant pairings, specifically CTAB–Tween 80, are optimal for stability and droplet-size control. CTAB is applied in the oil phase above its critical micelle concentration (CMC $\approx 0.9$ mM); Tween 80 is dosed in the aqueous phases at $10$–$100\%$ of its CMC ($\approx 0.015$ mM). Packing parameter analysis ($P=v/(a_0\ell_c)$) for both CTAB and Tween 80 supports stabilization of flat to mildly curved oil–water films, preventing micelle-induced oil uptake (Dhumal, 10 Jan 2026). The combination yields the smallest observed mean droplet sizes ($\sim 3\,\mu$m) with minimal growth over $0$–$4$ hours. Coarsening follows Ostwald ripening kinetics:

$$\frac{dR}{dt} = \frac{D\,C_\infty}{\rho R}\frac{2\gamma_{ow}V_m}{RT}$$

with linear suppression of ripening rate by decreased interfacial tension.

4. Curcumin Loading and Intradroplet Precipitation Dynamics

Curcumin is loaded at $30$ mg per batch via dissolution in the oil phase prior to emulsification. Upon W/O/W formation, water migrates across the oil shell, creating local supersaturation and driving nucleation per classical nucleation theory:

$$J \approx A\,\exp\Bigl[-\Delta G^*/(k_BT)\Bigr],\qquad \Delta G^* = \frac{16\pi\gamma_{co}^3}{3(\Delta\mu)^2}$$

where $\Delta G^*$ is nucleation barrier and $\Delta\mu$ is chemical potential change. Subsequent growth of curcumin nuclei is diffusion-limited within the water core. Optical microscopy reveals an initial increase and subsequent stabilization in mean particulate size, plateauing in the submicron to micron range (Dhumal, 10 Jan 2026).

5. Particle Characterization and Release Modeling

W/O/W-generated curcumin particulates, as documented by optical microscopy, exhibit number-averaged diameters ($\bar{d}\sim0.5$–$2\,\mu$m$)$ with $D_{50}\approx0.7\,\mu$m and $D_{90}\approx1.5\,\mu$m for CTAB–Tween 80 formulations. Morphology remains spherical; no TEM/SEM data provided. Encapsulation efficiency and loading capacity are not quantified; in vitro release kinetics are not experimentally reported (Dhumal, 10 Jan 2026).

Mechanistic release modeling via core–shell diffusion equations (Pontrelli et al., 2020) considers concentric regions (core $\Omega_0$, shell $\Omega_1$, external $\Omega_2$), governed by:

$$\frac{\partial C_i}{\partial t} = D_i\,\nabla^2 C_i$$

with interfacial continuity of concentration and flux, and mass-transfer resistance at the shell–external boundary:

$$-\,D_1\,\frac{\partial C_1}{\partial n}\Big|_{r=R} = k_m\,[C_1(R,t)-C_\infty]$$

Finite-volume numerical integration on unstructured meshes yields release curves; shape (ellipse, bullet, sphere), shell thickness ($R_1$–$R_0$), and surfactant permeability ($k_m$) critically affect time to achieve defined release fractions.

Geometry	$RT_{100\%}$ (h)	$RT_{80\%}$ (h)
Circle	19.5	$\sim$12.0
Ellipse	7.2	$\sim$4.2
Bullet	17.9	$\sim$10.5

Typical physical parameters for curcumin: $D_0\sim1\times10^{-10}\,\mathrm{m}^2/\mathrm{s}$ (water), $D_1\sim1\times10^{-13}\,\mathrm{m}^2/\mathrm{s}$ (oil), $k_m\sim2\times10^{-4}\,\mathrm{m}/\mathrm{s}$. Release time ($RT$) for $80\%$ curcumin can be tuned via geometry and surfactant layer permeability (Pontrelli et al., 2020).

6. Design Flexibility and Optimization Pathways

Compartmentalized “microreactor” behavior enables confined precipitation and mixing-sensitive control over particulate properties. Key optimization strategies include tuning energy density during sonication, adjusting surfactant concentrations to modulate interfacial stabilization, and varying oil shell thickness and phase composition for reduced ripening. Polymers (e.g., PVP) may be introduced for enhanced film rigidity and suppressed leakage. Further enhancement may include temperature–pH triggers for on-demand release.

Mechanistic modeling provides a route to target release profiles, e.g., achieving $80\%$ curcumin release at $12$ h by selecting elliptical drop geometry, shell thickness $R_1-R_0$, and $k_m$ within measurable limits. Empirical and simulated design iteration aligns load/release characteristics with pharmaceutical requirements (Dhumal, 10 Jan 2026, Pontrelli et al., 2020).

7. Implications and Future Directions

Curcumin-loaded W/O/W constructs exemplify the utility of multiple emulsions for confined precipitation, particle-size control, and sustained-release drug delivery. The platform is especially adapted to poorly soluble active pharmaceutical ingredients (APIs) requiring submicron engineering. While further quantification of encapsulation efficiency and dissolution kinetics is warranted, the established ultrasound-assisted protocol and mechanistic release models provide a scalable, tunable approach. Prospective advancements include high-throughput sonication reactors, advanced interfacial characterization, and integrated process–release modeling for smart delivery systems.

A plausible implication is that integration of advanced surfactant/interfacial rheology assays (e.g., DLS, NTA, electron microscopy) with mathematical modeling will accelerate the rational design of W/O/W constructs for specific APIs, aligning formulation engineering with desired in vitro/in vivo release profiles.